Keywords: Vaccines, Prices, Gavi Alliance, Pentavalent, Developing countries
GAVI’s impact on vaccine market is bringing down prices, the charity claims
Article | 18 November 2009
Following the increasing impact of the Geneva, Switzerland-based public-private partnership the Gavi Alliance on the vaccine market, the price of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
